Jumjum Pharma shares climb after breakout
The share of Jami Jamaam Pharma continues to rise after breaking through the resistance of the sideways range around 157.80 riyals, with a target of 162.80 riyals, supported by its stability above the main moving averages. It is anticipated to maintain its upward trend if it surpasses the level of 163.70 riyals, with a key support at 157.80 riyals. The stock experienced sideways movement in January 2026, then declined before regaining its balance and resuming its ascent through breaking the resistance at 143.40 riyals.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)